Palladium Complexes with Tridentate N-Heterocyclic Carbene Ligands: Selective "normal" and "abnormal" Bindings and Their Anticancer Activities

Jing Yi Lee, Jhen Yi Lee, Yuan Yu Chang, Ching-Han Hu, Miau-Yaun Wang, Hon Man Lee

Research output: Contribution to journalArticle

32 Citations (Scopus)

Abstract

A series of new imidazolium salts was synthesized by simple quaternization reactions of 1-benzyl-1H-imidazole or 1-benzyl-2-methyl-1H-imidazole and their derivatives with 2-chloro-N-(pyridin-2-ylmethyl)acetamide. These resulting imidazolium salts were successfully employed as ligand precursors for the syntheses of novel palladium(II) complexes bearing tridentate ligands of N-heterocyclic carbene, amidate, and pyridine donor moieties. Simple tuning of the reaction conditions allowed selective coordination of the N-heterocyclic carbene moiety in either "normal" or "abnormal" binding modes. An isomeric pair of palladium complexes with "normal" and "abnormal" N-heterocyclic carbenes was successfully characterized by single-crystal X-ray diffraction studies. Theoretical calculations indicated that the palladium complex with "normal" NHC coordination was more thermally stable than its isomeric complex with "abnormal" NHC binding. The potential of these two sets of palladium complexes as anticancer drugs was evaluated, and the results showed that some of these novel complexes exhibited promising inhibition activity against human ovarian cancer cell lines. The inhibition activity of these novel complexes was highly structurally dependent. While the nNHC complex bearing an N-3-methoxybenzyl group appeared to be the most active compound, its isomeric aNHC complex did not exhibit any inhibition activity toward TOV21G cells. In contrast, in the case of an isomeric pair of palladium complexes bearing N-4-fluorobenzyl groups, the aNHC complex showed activity superior to that of the nNHC complex.

Original languageEnglish
Pages (from-to)4359-4368
Number of pages10
JournalOrganometallics
Volume34
Issue number17
DOIs
Publication statusPublished - 2015 Sep 14

Fingerprint

Palladium
carbenes
Bearings (structural)
palladium
Ligands
ligands
imidazoles
Salts
salts
cultured cells
pyridines
drugs
Tuning
cancer
tuning
Cells
carbene
Single crystals
Derivatives
X ray diffraction

All Science Journal Classification (ASJC) codes

  • Physical and Theoretical Chemistry
  • Organic Chemistry
  • Inorganic Chemistry

Cite this

@article{f260c9d0b533458c8ebb4a4a95781bd2,
title = "Palladium Complexes with Tridentate N-Heterocyclic Carbene Ligands: Selective {"}normal{"} and {"}abnormal{"} Bindings and Their Anticancer Activities",
abstract = "A series of new imidazolium salts was synthesized by simple quaternization reactions of 1-benzyl-1H-imidazole or 1-benzyl-2-methyl-1H-imidazole and their derivatives with 2-chloro-N-(pyridin-2-ylmethyl)acetamide. These resulting imidazolium salts were successfully employed as ligand precursors for the syntheses of novel palladium(II) complexes bearing tridentate ligands of N-heterocyclic carbene, amidate, and pyridine donor moieties. Simple tuning of the reaction conditions allowed selective coordination of the N-heterocyclic carbene moiety in either {"}normal{"} or {"}abnormal{"} binding modes. An isomeric pair of palladium complexes with {"}normal{"} and {"}abnormal{"} N-heterocyclic carbenes was successfully characterized by single-crystal X-ray diffraction studies. Theoretical calculations indicated that the palladium complex with {"}normal{"} NHC coordination was more thermally stable than its isomeric complex with {"}abnormal{"} NHC binding. The potential of these two sets of palladium complexes as anticancer drugs was evaluated, and the results showed that some of these novel complexes exhibited promising inhibition activity against human ovarian cancer cell lines. The inhibition activity of these novel complexes was highly structurally dependent. While the nNHC complex bearing an N-3-methoxybenzyl group appeared to be the most active compound, its isomeric aNHC complex did not exhibit any inhibition activity toward TOV21G cells. In contrast, in the case of an isomeric pair of palladium complexes bearing N-4-fluorobenzyl groups, the aNHC complex showed activity superior to that of the nNHC complex.",
author = "Lee, {Jing Yi} and Lee, {Jhen Yi} and Chang, {Yuan Yu} and Ching-Han Hu and Miau-Yaun Wang and Lee, {Hon Man}",
year = "2015",
month = "9",
day = "14",
doi = "10.1021/acs.organomet.5b00586",
language = "English",
volume = "34",
pages = "4359--4368",
journal = "Organometallics",
issn = "0276-7333",
publisher = "American Chemical Society",
number = "17",

}

Palladium Complexes with Tridentate N-Heterocyclic Carbene Ligands : Selective "normal" and "abnormal" Bindings and Their Anticancer Activities. / Lee, Jing Yi; Lee, Jhen Yi; Chang, Yuan Yu; Hu, Ching-Han; Wang, Miau-Yaun; Lee, Hon Man.

In: Organometallics, Vol. 34, No. 17, 14.09.2015, p. 4359-4368.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Palladium Complexes with Tridentate N-Heterocyclic Carbene Ligands

T2 - Selective "normal" and "abnormal" Bindings and Their Anticancer Activities

AU - Lee, Jing Yi

AU - Lee, Jhen Yi

AU - Chang, Yuan Yu

AU - Hu, Ching-Han

AU - Wang, Miau-Yaun

AU - Lee, Hon Man

PY - 2015/9/14

Y1 - 2015/9/14

N2 - A series of new imidazolium salts was synthesized by simple quaternization reactions of 1-benzyl-1H-imidazole or 1-benzyl-2-methyl-1H-imidazole and their derivatives with 2-chloro-N-(pyridin-2-ylmethyl)acetamide. These resulting imidazolium salts were successfully employed as ligand precursors for the syntheses of novel palladium(II) complexes bearing tridentate ligands of N-heterocyclic carbene, amidate, and pyridine donor moieties. Simple tuning of the reaction conditions allowed selective coordination of the N-heterocyclic carbene moiety in either "normal" or "abnormal" binding modes. An isomeric pair of palladium complexes with "normal" and "abnormal" N-heterocyclic carbenes was successfully characterized by single-crystal X-ray diffraction studies. Theoretical calculations indicated that the palladium complex with "normal" NHC coordination was more thermally stable than its isomeric complex with "abnormal" NHC binding. The potential of these two sets of palladium complexes as anticancer drugs was evaluated, and the results showed that some of these novel complexes exhibited promising inhibition activity against human ovarian cancer cell lines. The inhibition activity of these novel complexes was highly structurally dependent. While the nNHC complex bearing an N-3-methoxybenzyl group appeared to be the most active compound, its isomeric aNHC complex did not exhibit any inhibition activity toward TOV21G cells. In contrast, in the case of an isomeric pair of palladium complexes bearing N-4-fluorobenzyl groups, the aNHC complex showed activity superior to that of the nNHC complex.

AB - A series of new imidazolium salts was synthesized by simple quaternization reactions of 1-benzyl-1H-imidazole or 1-benzyl-2-methyl-1H-imidazole and their derivatives with 2-chloro-N-(pyridin-2-ylmethyl)acetamide. These resulting imidazolium salts were successfully employed as ligand precursors for the syntheses of novel palladium(II) complexes bearing tridentate ligands of N-heterocyclic carbene, amidate, and pyridine donor moieties. Simple tuning of the reaction conditions allowed selective coordination of the N-heterocyclic carbene moiety in either "normal" or "abnormal" binding modes. An isomeric pair of palladium complexes with "normal" and "abnormal" N-heterocyclic carbenes was successfully characterized by single-crystal X-ray diffraction studies. Theoretical calculations indicated that the palladium complex with "normal" NHC coordination was more thermally stable than its isomeric complex with "abnormal" NHC binding. The potential of these two sets of palladium complexes as anticancer drugs was evaluated, and the results showed that some of these novel complexes exhibited promising inhibition activity against human ovarian cancer cell lines. The inhibition activity of these novel complexes was highly structurally dependent. While the nNHC complex bearing an N-3-methoxybenzyl group appeared to be the most active compound, its isomeric aNHC complex did not exhibit any inhibition activity toward TOV21G cells. In contrast, in the case of an isomeric pair of palladium complexes bearing N-4-fluorobenzyl groups, the aNHC complex showed activity superior to that of the nNHC complex.

UR - http://www.scopus.com/inward/record.url?scp=84941591540&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84941591540&partnerID=8YFLogxK

U2 - 10.1021/acs.organomet.5b00586

DO - 10.1021/acs.organomet.5b00586

M3 - Article

AN - SCOPUS:84941591540

VL - 34

SP - 4359

EP - 4368

JO - Organometallics

JF - Organometallics

SN - 0276-7333

IS - 17

ER -